Avantis' Third Eye gets $12m backing:
This article was originally published in Clinica
Executive Summary
Avantis Medical Systems is pushing forward the development and commercialisation of its leading colonoscopy device, the Third Eye Retroscope, after securing $12m in a series B round. Menlo Park, California-based VC firm Montreux Equity Partners led the financing. The Third Eye Retroscope works in tandem with a standard colonscope and is designed to detect polyps, cancers and other lesions hidden in the folds of the colon wall. A first human use study is currently in progress and a larger trial will be launched in the first quarter of 2007, says Sunnyvale, California-based Avantis.